Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review.
By G. Pearson, J. Veille, S. Rahimtoola, Judith Hsia, C. Oakley, J. Hosenpud, A. Ansari, K. Baughman. Journal of the American Medical Association (JAMA), 2000
787 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/756150d090491e3f7ce517dcd2b56069de2262cc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy (2010, background): “Peripartum cardiomyopathy has been variably defined (Table 1).(2,6,7) The definition of the Workshop held by the National Heart Lung and Blood Institute and the Office of Rare Diseases (2000) states that it must develop during the last month of pregnancy or within 5 months of delivery.”